{"id":"https://openalex.org/W4389453093","doi":"https://doi.org/10.1002/acr2.11630","title":"Anti\u2013Peptidylarginine Deiminase 4 Autoantibodies and Disease Duration as Predictors of Treatment Response in Rheumatoid Arthritis","display_name":"Anti\u2013Peptidylarginine Deiminase 4 Autoantibodies and Disease Duration as Predictors of Treatment Response in Rheumatoid Arthritis","publication_year":2023,"publication_date":"2023-12-07","ids":{"openalex":"https://openalex.org/W4389453093","doi":"https://doi.org/10.1002/acr2.11630","pmid":"https://pubmed.ncbi.nlm.nih.gov/38058274","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10867292"},"language":"en","primary_location":{"id":"doi:10.1002/acr2.11630","doi":"https://doi.org/10.1002/acr2.11630","is_oa":true,"landing_page_url":"https://doi.org/10.1002/acr2.11630","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acr2.11630","source":{"id":"https://openalex.org/S4210182786","display_name":"ACR Open Rheumatology","issn_l":"2578-5745","issn":["2578-5745"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACR Open Rheumatology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acr2.11630","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036748733","display_name":"Laura C. Cappelli","orcid":"https://orcid.org/0000-0003-2795-7059","observed_orcids":["https://orcid.org/0000-0003-2795-7059"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Laura C. Cappelli","raw_affiliation_strings":["Johns Hopkins School of Medicine, Baltimore, Maryland"],"raw_orcid":"https://orcid.org/0000-0003-2795-7059","affiliations":[{"raw_affiliation_string":"Johns Hopkins School of Medicine, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086113043","display_name":"David W. Hines","orcid":"https://orcid.org/0009-0000-8288-0029","observed_orcids":["https://orcid.org/0009-0000-8288-0029"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Hines","raw_affiliation_strings":["Johns Hopkins School of Medicine, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins School of Medicine, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100370865","display_name":"Hong Wang","orcid":"https://orcid.org/0000-0001-6258-4070","observed_orcids":["https://orcid.org/0000-0001-6258-4070","https://orcid.org/0000-0001-8538-6560"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hong Wang","raw_affiliation_strings":["Johns Hopkins School of Medicine, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins School of Medicine, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104520389","display_name":"Clifton O. Bingham","orcid":"https://orcid.org/0000-0002-4752-5029","observed_orcids":["https://orcid.org/0000-0002-4752-5029"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Clifton O. Bingham","raw_affiliation_strings":["Johns Hopkins School of Medicine, Baltimore, Maryland"],"raw_orcid":"https://orcid.org/0000-0002-4752-5029","affiliations":[{"raw_affiliation_string":"Johns Hopkins School of Medicine, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057205976","display_name":"Erika Darrah","orcid":"https://orcid.org/0000-0003-1119-0279","observed_orcids":["https://orcid.org/0000-0003-1119-0279"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Erika Darrah","raw_affiliation_strings":["Johns Hopkins School of Medicine, Baltimore, Maryland"],"raw_orcid":"https://orcid.org/0000-0003-1119-0279","affiliations":[{"raw_affiliation_string":"Johns Hopkins School of Medicine, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5036748733","https://openalex.org/A5057205976"],"corresponding_institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"],"apc_list":{"value":3080,"currency":"USD","value_usd":3080},"apc_paid":{"value":3080,"currency":"USD","value_usd":3080},"fwci":2.5135,"has_fulltext":true,"cited_by_count":12,"citation_normalized_percentile":{"value":0.90140729,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"6","issue":"2","first_page":"81","last_page":"90"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pad4","display_name":"PAD4","score":0.9850000143051147},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9480000138282776},{"id":"https://openalex.org/keywords/early-rheumatoid-arthritis","display_name":"early rheumatoid arthritis","score":0.878000020980835},{"id":"https://openalex.org/keywords/established-rheumatoid-arthritis","display_name":"established rheumatoid arthritis","score":0.9070000052452087},{"id":"https://openalex.org/keywords/disease-duration","display_name":"disease duration","score":0.9359999895095825},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.6639999747276306},{"id":"https://openalex.org/keywords/tofacitinib","display_name":"tofacitinib","score":0.968999981880188},{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":0.878000020980835},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9929999709129333},{"id":"https://openalex.org/keywords/disease-activity","display_name":"disease activity","score":0.47600001096725464},{"id":"https://openalex.org/keywords/joint-damage","display_name":"joint destruction","score":0.871999979019165},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7900000214576721},{"id":"https://openalex.org/keywords/therapeutic-window","display_name":"therapeutic window","score":0.6290000081062317}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9111323356628418},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.8293799161911011},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.75383460521698},{"id":"https://openalex.org/C2778886723","wikidata":"https://www.wikidata.org/wiki/Q3530324","display_name":"Tofacitinib","level":3,"score":0.73307204246521},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.6962217688560486},{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.6606937646865845},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.6417081356048584},{"id":"https://openalex.org/C163764329","wikidata":"https://www.wikidata.org/wiki/Q785022","display_name":"Autoantibody","level":3,"score":0.6235275268554688},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4853886365890503},{"id":"https://openalex.org/C45189115","wikidata":"https://www.wikidata.org/wiki/Q502159","display_name":"Serology","level":3,"score":0.4464065730571747},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4393959045410156},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.43803030252456665},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.4120345115661621},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.35708945989608765}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1002/acr2.11630","doi":"https://doi.org/10.1002/acr2.11630","is_oa":true,"landing_page_url":"https://doi.org/10.1002/acr2.11630","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acr2.11630","source":{"id":"https://openalex.org/S4210182786","display_name":"ACR Open Rheumatology","issn_l":"2578-5745","issn":["2578-5745"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACR Open Rheumatology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10867292","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10867292","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10867292/pdf/ACR2-6-81.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACR Open Rheumatol","raw_type":"Text"},{"id":"pmid:38058274","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38058274","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACR open rheumatology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:b845949a79f34d05af4ffaa6255e3db8","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/b845949a79f34d05af4ffaa6255e3db8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ACR Open Rheumatology, Vol 6, Iss 2, Pp 81-90 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1002/acr2.11630","doi":"https://doi.org/10.1002/acr2.11630","is_oa":true,"landing_page_url":"https://doi.org/10.1002/acr2.11630","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acr2.11630","source":{"id":"https://openalex.org/S4210182786","display_name":"ACR Open Rheumatology","issn_l":"2578-5745","issn":["2578-5745"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACR Open Rheumatology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.7699999809265137,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8654038133","display_name":"Understanding Inflammatory Arthritis due to Immune Checkpoint Inhibitors","funder_award_id":"K23AR075872","funder_id":"https://openalex.org/F4320337362","funder_display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"},{"id":"https://openalex.org/G9000902966","display_name":"Johns Hopkins Rheumatic Diseases Resource-based Core Center (Johns Hopkins RDRCC)","funder_award_id":"P30AR070254","funder_id":"https://openalex.org/F4320337362","funder_display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"}],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337362","display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","ror":"https://ror.org/006zn3t30"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4389453093.pdf","grobid_xml":"https://content.openalex.org/works/W4389453093.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W1534043095","https://openalex.org/W1867131794","https://openalex.org/W1901640178","https://openalex.org/W1983929025","https://openalex.org/W1985498235","https://openalex.org/W1996443264","https://openalex.org/W2014330392","https://openalex.org/W2061641531","https://openalex.org/W2069302785","https://openalex.org/W2071563106","https://openalex.org/W2125930376","https://openalex.org/W2138526118","https://openalex.org/W2143213398","https://openalex.org/W2159106700","https://openalex.org/W2161396597","https://openalex.org/W2402220401","https://openalex.org/W2532688966","https://openalex.org/W2793547099","https://openalex.org/W2809839732","https://openalex.org/W2897820616","https://openalex.org/W2903431204","https://openalex.org/W2914217034","https://openalex.org/W2915909113","https://openalex.org/W2930775135","https://openalex.org/W3081915027","https://openalex.org/W4200405895","https://openalex.org/W4321612971"],"related_works":["https://openalex.org/W2903431204","https://openalex.org/W2161396597","https://openalex.org/W2143213398","https://openalex.org/W2331492170","https://openalex.org/W2897820616","https://openalex.org/W2771284437","https://openalex.org/W2141342904","https://openalex.org/W4282931474","https://openalex.org/W2972517766","https://openalex.org/W2206157289"],"abstract_inverted_index":{"BACKGROUND:":[0],"Given":[1],"that":[2],"autoantibodies":[3],"to":[4,23,110,118,254,270],"peptidylarginine":[5],"deiminase":[6],"4":[7],"(PAD4)":[8],"are":[9],"associated":[10,142,158],"with":[11,35,44,71,132,143,159,176,178,281,283],"erosive":[12],"disease":[13,115,164,221],"in":[14,33,126,148,163,198,219,225,238,246,258,278],"established":[15,38,53,135,149,201,239,261],"rheumatoid":[16],"arthritis":[17],"(RA),":[18],"this":[19],"study":[20],"was":[21,187],"conducted":[22],"compare":[24],"the":[25,81,264,272],"clinical":[26,64,112,196,248],"and":[27,37,85,90,101,104,128,134,141,200,231,250,260],"prognostic":[28],"use":[29],"of":[30,66,83,130,204,234,266,274],"anti-PAD4":[31,84,119,155,180,205,255,284],"antibodies":[32,87,123,156],"patients":[34,43,131,280],"early":[36,45,133,152,199,226,259,279],"RA.":[39,150],"METHODS:":[40],"Sera":[41],"from":[42,61],"(duration":[46,54],"<2":[47],"years;":[48,56],"n":[49,57],"=":[50,58,182,229,242],"422)":[51],"or":[52,75],"\u22652":[55],"359)":[59],"RA":[60,227,240,262,282],"two":[62],"randomized":[63],"trials":[65],"tofacitinib":[67],"\u00b1":[68,185],"methotrexate":[69],"compared":[70,175],"adalimumab":[72,213],"+":[73,214],"MTX":[74,76,186,192,215],"alone":[77,193],"were":[78,96,108,124,157],"evaluated":[79],"for":[80,98,210],"presence":[82],"anti-PAD3/4":[86],"at":[88,194],"baseline":[89,144,154],"posttreatment":[91],"time":[92],"points.":[93],"Summary":[94],"statistics":[95],"calculated":[97],"demographic,":[99],"clinical,":[100],"serological":[102],"characteristics,":[103],"generalized":[105],"estimating":[106],"equations":[107],"used":[109],"model":[111],"outcomes":[113,197,252],"by":[114],"duration":[116],"according":[117,253],"status.":[120],"RESULTS:":[121],"Anti-PAD4":[122],"present":[125],"22%":[127],"40%":[129],"RA,":[136,153,202],"respectively,":[137],"stable":[138],"following":[139],"treatment,":[140],"joint":[145,276],"damage":[146,277],"only":[147],"In":[151],"a":[160,267],"greater":[161],"improvement":[162],"activity":[165,222],"score":[166,223],"28-joint":[167],"count":[168],"using":[169],"C-reactive":[170],"protein":[171],"levels":[172],"after":[173],"treatment":[174],"individuals":[177],"negative":[179],"(P":[181,207,228,241],"0.049).":[183],"Tofacitinib":[184],"more":[188],"broadly":[189],"efficacious":[190],"than":[191],"improving":[195],"irrespective":[203],"status":[206,257],"<":[208],"0.05":[209],"all),":[211],"whereas":[212],"exhibited":[216],"differential":[217],"benefits":[218],"achieving":[220],"remission":[224],"0.036)":[230],"American":[232],"College":[233],"Rheumatology":[235],"20":[236],"responses":[237],"0.002).":[243],"CONCLUSION:":[244],"Differences":[245],"prevalence,":[247],"associations,":[249],"treatment-response":[251],"antibody":[256],"suggests":[263],"existence":[265],"therapeutic":[268],"window":[269],"prevent":[271],"accumulation":[273],"irreversible":[275],"antibodies.":[285]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2023-12-08T00:00:00"}